Advertisement
Screener

SYROS PHARMACEUTICALS, INC. Accounts Payable

SYROS PHARMACEUTICALS, INC. Accounts Payable

SYROS PHARMACEUTICALS, INC. had Accounts Payable of $9.65 million as of 2024-09-30, per its 10-Q filed 2024-10-31.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current

us-gaap:AccountsPayableCurrent · last filed 2024-10-31

  • 2024-09-30: Accounts Payable, Current $9.65M.
  • 2024-06-30: Accounts Payable, Current $7.47M.
  • 2024-03-31: Accounts Payable, Current $11.35M.
  • 2023-12-31: Accounts Payable, Current $11.54M.
Period endAccounts Payable, Current
2024-09-30$9.65M
10-Q · filed 2024-10-31
2024-06-30$7.47M
10-Q · filed 2024-07-31
2024-03-31$11.35M
10-Q · filed 2024-05-14
2023-12-31$11.54M
10-Q · filed 2024-10-31
2023-09-30$2.85M
10-Q · filed 2023-11-14
2023-06-30$6.69M
10-Q · filed 2023-08-08
2023-03-31$2.79M
10-Q · filed 2023-05-10
2022-12-31$6.41M
10-K · filed 2024-03-27
2022-09-30$13.02M
10-Q · filed 2022-11-14
2022-06-30$6.12M
10-Q · filed 2022-08-09
2022-03-31$2.84M
10-Q · filed 2022-05-16
2021-12-31$3.69M
10-K · filed 2023-03-02
2021-09-30$4.11M
10-Q · filed 2021-11-05
2021-06-30$3.67M
10-Q · filed 2021-08-05
2021-03-31$3.66M
10-Q · filed 2021-05-06
2020-12-31$3.60M
10-K · filed 2022-03-15
2020-09-30$4.94M
10-Q · filed 2020-11-05
2020-06-30$2.80M
10-Q · filed 2020-08-06
2020-03-31$4.64M
10-Q · filed 2020-05-07
2019-12-31$5.85M
10-K · filed 2021-03-04
2019-09-30$8.04M
10-Q · filed 2019-11-12
2019-06-30$1.76M
10-Q · filed 2019-08-01
2019-03-31$2.63M
10-Q · filed 2019-05-01
2018-12-31$3.31M
10-K · filed 2020-03-05
2018-09-30$2.67M
10-Q · filed 2018-11-01
2018-06-30$1.26M
10-Q · filed 2018-08-07
2018-03-31$1.72M
10-Q · filed 2018-05-10
2017-12-31$2.28M
10-K · filed 2019-03-07
2017-09-30$1.85M
10-Q · filed 2017-11-08
2017-06-30$1.35M
10-Q · filed 2017-08-09
2017-03-31$2.38M
10-Q · filed 2017-05-15
2016-12-31$2.42M
10-K · filed 2018-03-12
2016-09-30$4.04M
10-Q · filed 2016-11-14
2016-06-30$1.65M
10-Q · filed 2016-08-15
2015-12-31$5.04M
10-K · filed 2017-03-20